As of 2025-09-18, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (46.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.90 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -1689.8%.
The range of the Relative Valuation is (44.72) - (47.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.6x | 13.2x |
| Forward P/E multiples | 12.8x - 13.5x | 13.2x |
| Fair Price | (44.72) - (47.38) | (46.10) |
| Upside | -1642.1% - -1733.8% | -1689.8% |
| Date | P/E |
| 2025-09-15 | -0.91 |
| 2025-09-12 | -0.89 |
| 2025-09-11 | -0.97 |
| 2025-09-10 | -1.01 |
| 2025-09-09 | -1.02 |
| 2025-09-08 | -1.21 |
| 2025-09-05 | -1.08 |
| 2025-09-04 | -1.02 |
| 2025-09-03 | -1.03 |
| 2025-09-02 | -1.09 |
| 2025-08-29 | -1.16 |
| 2025-08-28 | -1.17 |
| 2025-08-27 | -1.13 |
| 2025-08-26 | -1.50 |
| 2025-08-25 | -1.47 |
| 2025-08-22 | -1.42 |
| 2025-08-21 | -1.49 |
| 2025-08-20 | -1.44 |
| 2025-08-19 | -1.41 |
| 2025-08-18 | -1.62 |
| 2025-08-15 | -1.57 |
| 2025-08-14 | -1.36 |
| 2025-08-13 | -1.60 |
| 2025-08-12 | -1.94 |
| 2025-08-11 | -1.83 |
| 2025-08-08 | -1.15 |
| 2025-08-07 | -0.97 |
| 2025-08-06 | -0.95 |
| 2025-08-05 | -0.85 |
| 2025-08-04 | -0.73 |
| 2025-08-01 | -0.39 |
| 2025-07-31 | -0.37 |
| 2025-07-30 | -0.41 |
| 2025-07-29 | -0.45 |
| 2025-07-28 | -0.49 |
| 2025-07-25 | -0.52 |
| 2025-07-24 | -0.49 |
| 2025-07-23 | -0.52 |
| 2025-07-22 | -0.52 |
| 2025-07-21 | -0.54 |
| 2025-07-18 | -0.55 |
| 2025-07-17 | -0.55 |
| 2025-07-16 | -0.56 |
| 2025-07-15 | -0.54 |
| 2025-07-14 | -0.58 |
| 2025-07-11 | -0.56 |
| 2025-07-10 | -0.57 |
| 2025-07-09 | -0.57 |
| 2025-07-08 | -0.57 |
| 2025-07-07 | -0.54 |